UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
PUT
Boston Scientific
BSX
$72B
| $24.3M | 0.01% |
315,600
+6,200
| +2% | +$454K |
|
|
B
1527
PUT
Barrick Mining
B
$69.3B
| $24.3M | 0.01% |
1,456,200
-1,575,900
| -52% | -$26.8M |
|
1528
PIMCO Dynamic Income Fund
PDI
$7.42B
| $24.3M | 0.01% |
1,290,389
-56,858
| -4% | -$1.09M |
|
|
IGR
1529
CBRE Global Real Estate Income Fund
IGR
$713M
| $24.3M | 0.01% |
4,812,999
-58,694
| -1% | -$295K |
|
1530
Carlisle Companies
CSL
$15.3B
| $24.2M | 0.01% |
59,790
+4,716
| +9% | +$1.9M |
|
1531
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.8B
| $24.2M | 0.01% |
346,209
-4,452
| -1% | -$292K |
|
1532
Revvity
RVTY
$12.6B
| $24.2M | 0.01% |
230,388
+47,920
| +26% | +$5.09M |
|
1533
Curtiss-Wright
CW
$26.8B
| $24.1M | 0.01% |
89,036
+7,233
| +9% | +$1.93M |
|
1534
PUT
Halliburton
HAL
$27B
| $24.1M | 0.01% |
714,200
-1,072,500
| -60% | -$39.6M |
|
1535
iShares MSCI Australia ETF
EWA
$1.44B
| $24.1M | 0.01% |
985,645
-459,410
| -32% | -$11.2M |
|
1536
First Trust Natural Gas ETF
FCG
$617M
| $24M | 0.01% |
913,741
+2,265
| +0.2% | +$61.5K |
|
|
THS
1537
DELISTED
Treehouse Foods
THS
| $24M | 0.01% |
654,902
-29,416
| -4% | -$1.07M |
|
1538
PUT
Mondelez International
MDLZ
$80.3B
| $24M | 0.01% |
366,600
+3,500
| +1% | +$240K |
|
1539
First Trust Health Care AlphaDEX Fund
FXH
$1.05B
| $24M | 0.01% |
229,149
-6,543
| -3% | -$687K |
|
1540
Hasbro
HAS
$13B
| $23.9M | 0.01% |
409,128
+55,555
| +16% | +$3.3M |
|
1541
Cheniere Energy
CQP
$32.1B
| $23.9M | 0.01% |
487,043
+10,564
| +2% | +$512K |
|
1542
PUT
Nucor
NUE
$62.2B
| $23.9M | 0.01% |
151,000
+75,700
| +101% | +$13.2M |
|
1543
Crown Holdings
CCK
$13.2B
| $23.8M | 0.01% |
320,149
+114,232
| +55% | +$9.21M |
|
1544
NIO
NIO
$11.5B
| $23.8M | 0.01% |
5,724,462
+1,622,827
| +40% | +$7.68M |
|
1545
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.36B
| $23.8M | 0.01% |
535,430
+1,138
| +0.2% | +$50.2K |
|
1546
Camden Property Trust
CPT
$11B
| $23.8M | 0.01% |
217,695
-56,392
| -21% | -$5.82M |
|
1547
J.M. Smucker
SJM
$12.6B
| $23.7M | 0.01% |
217,785
+32,654
| +18% | +$3.69M |
|
1548
Timken Company
TKR
$9B
| $23.7M | 0.01% |
296,239
-25,967
| -8% | -$2.24M |
|
1549
Gen Digital
GEN
$16.2B
| $23.7M | 0.01% |
949,871
+113,264
| +14% | +$2.59M |
|
1550
Fluor
FLR
$6.9B
| $23.7M | 0.01% |
543,499
-56,757
| -9% | -$2.36M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.